Table 2.
Characteristics | COVID-19 | Control | ORs (95% Confidence Interval) for COVID-19 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
(Exposure/Total, %) | (Exposure/Total, %) | Crude † | p-Value | Model 1 †,‡ | p-Value | Model 2 †,§ | p-Value | Model 3 †,‖ | p-Value | |
Hypothyroidism | 284/8070 (3.5%) | 980/32,280 (3.0%) | 1.17 (1.02–1.34) | 0.025 * | 1.11 (0.97–1.28) | 0.126 | 1.12 (0.97–1.29) | 0.120 | 1.09 (0.95–1.26) | 0.229 |
Hyperthyroidism | 134/8070 (1.7%) | 531/32,280 (1.6%) | 1.01 (0.83–1.22) | 0.922 | 1.00 (0.82–1.21) | 0.983 | 0.98 (0.81–1.20) | 0.871 | N/A | |
Graves’ disease | 20/8070 (0.2%) | 97/32,280 (0.3%) | 0.82 (0.51–1.34) | 0.432 | 0.82 (0.51–1.33) | 0.423 | N/A | 0.79 (0.49–1.29) | 0.348 | |
Thyroiditis | 108/8070 (1.3%) | 423/32,280 (1.3%) | 1.02 (0.83–1.27) | 0.844 | 1.01 (0.81–1.25) | 0.930 | 0.98 (0.78–1.23) | 0.840 | N/A | |
Autoimmune thyroiditis | 52/8070 (0.6%) | 155/32,280 (0.5%) | 1.35 (0.98–1.85) | 0.065 | 1.32 (0.96–1.82) | 0.085 | N/A | 1.27 (0.92–1.77) | 0.146 |
CCI: Charlson comorbidity index; N/A: not applicable. * Conditional logistic regression, significance at p < 0.05. † Models were stratified by age, sex, and income. ‡ Model 1 was adjusted for CCI scores and hypertension. § Model 2 was adjusted for model 1 plus hypothyroidism, hyperthyroidism, and thyroiditis. ‖ Model 3 was adjusted for model 1 plus hypothyroidism, Graves’ disease, and autoimmune thyroiditis.